scispace - formally typeset
S

Sonia Kapur

Researcher at Loma Linda University

Publications -  5
Citations -  579

Sonia Kapur is an academic researcher from Loma Linda University. The author has contributed to research in topics: Phosphorylation & Kinase. The author has an hindex of 4, co-authored 5 publications receiving 552 citations.

Papers
More filters
Journal ArticleDOI

Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways

TL;DR: It is shown for the first time that the signal transduction mechanism of shear stress in osteoblasts is complex and involves multiple ERK-dependent and independent pathways, and circumstantial evidence that there may be a PTX-sensitive pathway that has completing effects with an unknown pathway on the differentiation of normal human osteoblast.
Journal ArticleDOI

Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear.

TL;DR: In this paper, a 30-min steady fluid shear of 20 dynes/cm2 increased [3H]thymidine incorporation and alkaline phosphatase activity and upregulated the expression of early mechanoresponsive genes (integrin β1 (Igtb1) and cyclooxygenase-2 (Cox-2), indicating that the differential mechanosensitivity was intrinsic to osteoblasts.
Journal ArticleDOI

Extracellular signal-regulated kinase-1 and -2 are both essential for the shear stress-induced human osteoblast proliferation.

TL;DR: It is demonstrated for the first time that Erk-1 and -2 are both required for the mitogenic response to fluid flow shear stress in human osteoblasts and that blocking ErK-1 or -2 each alone is sufficient to completely block the mitogenetic response to shear Stress-induced proliferation.
Journal ArticleDOI

Modifications of the fibroblast growth factor-2 gene led to a marked enhancement in secretion and stability of the recombinant fibroblast growth factor-2 protein.

TL;DR: The modifications did not alter the modified FGF‐2 protein’s ability to stimulate cell proliferation and Erk1/2 phosphorylation in marrow stromal cells or its ability to bind heparin in vitro, suggesting that it was functionally as effective as the unmodified F GF‐2.